STABILITY AND DISEASE TROPISM OF PROVIRAL DNAS
STABILITY AND DISEASE TROPISM OF PROVIRAL DNAS
批准号:
3170884
负责人:
Peter R. Shank
金额:
$13.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-07-01 至 1988-06-30
关键词:
Retroviridae disease avian leukosis virus clone cells gene expression genetic manipulation genetic recombination latent virus infection molecular cloning molecular oncology nucleic acid sequence oncogenes oncogenic virus osteopetrosis provirus temperature sensitive mutant transforming virus viral carcinogenesis virus DNA virus genetics virus replication
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We are studying two separate aspects of the biology of avian retroviruses:
the mechanism of induction of avian osteopetrosis and the stability of
proviral DNA. Avian retroviruses lacking oncogenes often produce primarily
one form of non-acute disease. We have termed this disease preference
"targeting." We are interested in defining which sequences in the viral
genome are responsible for osteopetrosis "targeting" as a start to
understanding the mechanism of disease induction. Our approach has been to
construct a molecular clone of a virus which "targets" toward osteopetrosis
(NTRE-2) and then to construct recombinant viruses by exchanging homologous
restriction endonulease frangments between NTRE-2 and a virus which
"targets" toward the production of lymphoma (RAV-60NY203) or which does not
produce disease (RAV-O). Results of these studies suggest that sequences
within the LTR are necessary for disease induction but that sequences
within the viral structural genes most probably in gag or pol are required
for the production of osteopetrosis. This represents the first association
of a viral structural protein with the production of disease. We will
extend these observations to smaller restriction fragments and ultimately
to the level of DNA sequence analysis and site specific mutagenesis to
define the sequences responsible for osteopetrosis induction.
The similarity in structure between retrovirus proviral DNA and
transposable genetic elements has been frequently commented upon. There is
however little if any eveidence that proviruses possess any of the
functional characteristics of transposable genetic elements. We have
observed "instability" in the pattern of proviral DNA in several clones of
td-RSV infected QT-6 cells. The patterns of "instability" observed include
both loss and gain of proviral sequences and propagation of deletions into
adjacent cellular DNA. We intend to use the techniques ol molecular
cloning, DNA sequencing and chromatin structure analysis to determine
whether specific sequences or DNA conformations can be correlated proviral
instability.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Nucleotide sequence comparison of the 3' regions of avian retroviruses NY203 and NTRE-2.
禽逆转录病毒 NY203 和 NTRE-2 3 区的核苷酸序列比较。
DOI:
10.1016/0042-6822(86)90112-1
发表时间:
1986
期刊:
Virology
影响因子:
3.7
作者:
[Leamnson,RN, Shank,PR]
通讯作者:
Shank,PR
IMPROVEMENT OF RES FACIL: BRAIN, PERCEPTION, COMPUTATIONAL SCI
-
批准号:6794350
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2002
-
负责人:Peter R. Shank
-
依托单位:
IMPROVEMENT OF RESEARCH FACILITY
-
批准号:6513996
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2002
-
负责人:Peter R. Shank
-
依托单位:
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION PROJECT
-
批准号:6258236
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2000
-
负责人:Peter R. Shank
-
依托单位:
CHARACTERIZATION OF HIV TAT-MEDIATED TRANSACTIVATION
-
批准号:3509511
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1991
-
负责人:Peter R. Shank
-
依托单位:
NON RAS ONCOGENES IN CHEMICALLY INDUCED RAT LIVER TUMORS
-
批准号:3190963
-
项目类别:
-
资助金额:$18.47万
-
财政年份:1988
-
负责人:Peter R. Shank
-
依托单位:
NON RAS ONCOGENES IN CHEMICALLY INDUCED RAT LIVER TUMORS
-
批准号:3190962
-
项目类别:
-
资助金额:$18.04万
-
财政年份:1988
-
负责人:Peter R. Shank
-
依托单位:
NON RAS ONCOGENES IN CHEMICALLY INDUED LIVER TUMORS
-
批准号:3190961
-
项目类别:
-
资助金额:$18.19万
-
财政年份:1988
-
负责人:Peter R. Shank
-
依托单位:
STABILITY AND DISEASE TROPISM OF PROVIRAL DNAS
-
批准号:3170882
-
项目类别:
-
资助金额:$13.49万
-
财政年份:1982
-
负责人:Peter R. Shank
-
依托单位:
STABILITY AND DISEASE TROPISM OF PROVIRAL DNAS
-
批准号:3170883
-
项目类别:
-
资助金额:$12.89万
-
财政年份:1982
-
负责人:Peter R. Shank
-
依托单位:
海外基金